Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$8.22 USD
+0.05 (0.61%)
Updated May 10, 2024 04:00 PM ET
After-Market: $8.22 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Price, Consensus and EPS Surprise
MD 8.22 +0.05(0.61%)
Will MD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MD
Pediatrix (MD) Q1 Earnings Beat on Hospital Contract Fees
Compared to Estimates, Pediatrix Medical Group (MD) Q1 Earnings: A Look at Key Metrics
MD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Life Time Group Holdings, Inc. (LTH) Q1 Earnings Miss Estimates
ICON (ICLR) Up 7.6% Since Last Earnings Report: Can It Continue?
Pediatrix Medical Group, Inc. (MD) Up 11% Since Last Earnings Report: Can It Continue?
Other News for MD
Maintaining Hold: Assessing Pediatrix Medical Group’s Rebound Amidst Restructuring and Rising Costs
Pediatrix Medical Group Underperform Rating Amidst Restructuring and Growth Challenges
Pediatrix Medical Group Inc (MD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Pediatrix Medical Group: Hold Rating Amidst Positive Birth Trends and Revenue Cycle Risks
Pediatrix Medical Group, Inc. (MD) Q1 2024 Earnings Call Transcript